Varenicline Tartrate Nasal Spray

DRUG2 trials

Sponsors

Corxel Pharmaceuticals

Conditions

Dry Eye Disease

Phase 1

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease

CompletedNCT05576415

Corxel PharmaceuticalsDry Eye Disease

Start: 2022-12-07End: 2023-04-27Updated: 2023-05-01

Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

CompletedNCT05378945

Corxel PharmaceuticalsDry Eye Disease

Start: 2022-07-22End: 2023-04-04Updated: 2023-04-25

Related Papers

Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trial.

2024-02-272 citations